Kenneth Cusi
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017/07/17 by Naga Chalasani, Zobair Younossi, Zobair M. Younossi +8 · 19 citations
Medicine · #Diet, Metabolism, and Disease #Liver Disease Diagnosis and Treatment #Liver Disease and Transplantation
- Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscle
2000/02/01 by Kenneth Cusi, Katsumi Maezono, Abdullah A. Osman +8 · 30 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Metabolism, Diabetes, and Cancer #Adipose Tissue and Metabolism #Pharmacology and Obesity Treatment
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
2016/06/20 by Kenneth Cusi, Beverly Orsak, Fernando Bril +12 · 32 citations
Medicine · #Liver Disease Diagnosis and Treatment #Diabetes, Cardiovascular Risks, and Lipoproteins #Diet and metabolism studies
- A multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023/06/22 by Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu +67 · 16 citations
Medicine · #Diet, Metabolism, and Disease #Liver Disease Diagnosis and Treatment #Liver Disease and Transplantation
- Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
2023/07/24 by Mazen Noureddin, Emily Truong, Rebeca Mayo +32 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Diabetes, Cardiovascular Risks, and Lipoproteins #Liver Disease Diagnosis and Treatment #Metabolomics and Mass Spectrometry Studies
- Summary of Revisions: Standards of Care in Diabetes—2025
2024/12/09 by Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo +53 · 2 citations
Medicine · #Clinical practice guidelines implementation #Diabetes Management and Education